Meet Genomadix™

Genomadix has developed the Cube, the world’s first real-time PCR point of need platform for precision medicine testing and other applications.
  • Genomadix produces molecular tests for precision medicine genotyping and environmental/water safety testing.
  • Genomadix commercializes the Cube CYP2C19 Genotyping Test, the world’s fastest and easiest FDA-cleared CYP2C19 genotyping test, which can be used to support dual antiplatelet therapy decisions for stroke and cardiology patients.
  • The Genomadix Cube is a point of care open platform, and is available for partnering with assay developers, clinical labs, laboratory service providers, and others.
  • Genomadix’s technology for the cube includes over 3 million hours of research and development, 11 patents and 23 peer-reviewed scientific publications

Management

Genomadix leadership team is comprised of visionary founders and seasoned professionals with decades of experience across diverse fields such as, life sciences, in vitro diagnostics, and high-tech. Together, they’ve achieved successful exits, launched innovative products, and spearheaded effective commercialization. Their combined expertise in business development, strategic planning, and international markets positions Genomadix for tremendous growth
Genomadix Steve Edgett

Steve Edgett

CEO

Read More +
Genomadix Jeremy Bridge Cook

Jeremy Bridge-Cook

Chief Scientific Officer (CSO) and Vice President, Research & Development (R&D)

Read More +
Genomadix Sean Tomalty

Sean Tomalty

Chief Operating Officer (COO)

Read More +
Genomadix Rick Clements

Rick Clements

Chief Financial Officer (CFO)

Read More +
Genomadix Patrick Mallon

Patrick Mallon

Exec Chairman

Read More +
Genomadix Joshua Van Wezel

Joshua van Wezel

Head of Sales

Read More +

Careers

Looking to join our growing team? Learn more about what it’s like to work at Genomadix and our current openings.
Join Our Team

Ready to start working with the
Genomadix Cube?

Contact Us
Genomadix Logo

Genomadix

555 Legget Dr Suite 900,
Kanata, ON K2K 3B8
1 877-228-7756

Technology

About

Legal

© 2024 Genomadix, the Genomadix logo and all product names are the property of Genomadix or its licensors. All rights reserved. 

Scroll to Top

Steve Edgett

CEO

Steve serves as Genomadix’s CEO after having led the acquisition of Genomadix Bioscience in 2022.  Previously, Edgett held the role of Executive Vice President of Genomadix Bioscience where he oversaw corporate strategy and international business development.  Steve has more than 20 years of experience in business development, strategic planning, and international markets.   He has founded and held senior leadership roles in several high-technology companies, including Knowmadics, Cobham PLC, EMS Technologies and Honeywell International.

Steve holds an Honours Bachelor of Applied Science in Systems Design Engineering from the University of Waterloo.

Jeremy bridge-Cook

Chief Scientific Officer (CSO) and Vice President, Research & Development (R&D)

Dr. Bridge-Cook has over 20 years of experience in various executive roles in the in vitro diagnostics industry. Prior to Genomadix, he was President & CEO of Rna Diagnostics Inc., a cancer diagnostic company based in Toronto, Canada. Prior to this position, Dr. Bridge-Cook held various executive positions at Luminex Corporation and Tm Bioscience (acquired by Luminex in 2007) for 16 years in positions of increasing responsibility. Dr. Bridge-Cook was VP of Business Development, VP Sales & Marketing and Senior VP Corporate Development at Tm Bioscience, and most recently served as Senior VP of Research & Development at Luminex Corp. While running R&D for Luminex Corp., Dr. Bridge-Cook led teams that developed the first FDA-cleared respiratory viral panel and the first FDA-cleared gastrointestinal pathogen panel, as well as developing and launching the ARIES system and several other instrument and assay launches. Prior to working at Luminex/Tm, Dr. Bridge-Cook worked as an Investment Manager at MDS Capital Corp., a venture capital company focused on Life Science investments. Dr. Bridge-Cook received his B.Sc. from McMaster University and Ph.D. in Immunology from the University of Toronto.

Sean tomalty

Cheif operating officer (COO)

Sean joined Genomadix in 2015 and is currently responsible for the Supply Chain, Manufacturing, Quality and Regulatory functions at Genomadix. Sean has more than 30 years of experience in operations and manufacturing at companies including Abbott point-of-care, JDSU, and Nortel.  He has developed supply chains and distribution network for high volume (50 million annual tests) using a combination of insource and 3.

Throughout his career he has worked in partnership with R&D functions to develop and launch new and innovative products in medical device and high tech (telephony) markets.

Sean holds a Bachelor of Mechanical Engineering degree from Carleton University and a Masters of Business Administration degree from Queen’s University.  He is a licensed Professional Engineer.

Rick Clements

Chief Financial Officer (CFO)

Rick joined Genomadix in 2020 and is responsible for the Companies finance and administration functions. Rick has a long career as CFO of various Companies, both Private & Public. Rick has a depth of diverse experience in various industries, such as manufacturing hardware (International Datacasting, Versatel Networks), natural health products manufacturing (St. Francis Herb Farm), in the consumer service industry with a hardware / software platform (FanVision LLC, Kanagroo TV, Inbusiness Solutions). Much of Rick’s career has been focused on leading companies through a transition, both financially, and, in many cases operationally as COO or VP Operations.

Rick has an Honours Bachelor of Chartered Accounting Studies from University of Waterloo and is a Chartered Professional Accountant.

Patrick Mallon

Exec Chairman

 

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Mauris vulputate quam non arcu viverra, at consectetur mi vestibulum. Nam lacinia velit sit amet sem rutrum, vel elementum lacus iaculis. Fusce quis auctor velit. Maecenas gravida enim sit amet sem aliquet, ut ullamcorper libero mattis. Etiam sodales pharetra augue, accumsan scelerisque turpis dignissim vel. Maecenas fermentum laoreet varius. Vestibulum non aliquam ligula. Sed metus mi, lobortis in velit semper, euismod mollis diam. Maecenas malesuada tincidunt lorem sit amet pharetra. Nunc tincidunt lacus id eros facilisis mollis. Proin mattis lobortis hendrerit. Maecenas blandit scelerisque felis at eleifend. Donec a tempus libero. Maecenas mollis nulla nisi, at iaculis turpis cursus vitae.

Joshua van Wezel

Head of Sales

 

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Mauris vulputate quam non arcu viverra, at consectetur mi vestibulum. Nam lacinia velit sit amet sem rutrum, vel elementum lacus iaculis. Fusce quis auctor velit. Maecenas gravida enim sit amet sem aliquet, ut ullamcorper libero mattis. Etiam sodales pharetra augue, accumsan scelerisque turpis dignissim vel. Maecenas fermentum laoreet varius. Vestibulum non aliquam ligula. Sed metus mi, lobortis in velit semper, euismod mollis diam. Maecenas malesuada tincidunt lorem sit amet pharetra. Nunc tincidunt lacus id eros facilisis mollis. Proin mattis lobortis hendrerit. Maecenas blandit scelerisque felis at eleifend. Donec a tempus libero. Maecenas mollis nulla nisi, at iaculis turpis cursus vitae.